First-Pass Clean Claim Rate
Prior Auth Approval Rate
Client Denial Rate (vs. 20% Industry Avg)
Average Days to Payment
Pain management billing operates in one of the highest-scrutiny environments in healthcare. Payers apply aggressive prior authorization requirements, medical necessity reviews, and post-payment audits to injection procedures, nerve blocks, and implantable device cases. Injection codes (64490-64495 for facet joint injections, 64483-64484 for transforaminal epidurals) and nerve block codes (64400-64450) require precise anatomical documentation, fluoroscopic guidance confirmation, and clear clinical rationale for each level treated.
Our pain management billing team navigates this challenging landscape by front-loading documentation review, managing prior authorizations proactively, and applying the coding precision that prevents denials before they happen. We handle the full spectrum of pain management procedures, from diagnostic and therapeutic injections to radiofrequency ablation (64625-64640), spinal cord stimulator trials and implants (63650-63688), and intrathecal drug delivery systems. With pain management denial rates industry-wide running 15% to 25%, our proactive approach keeps client denials well below the national average.
Every Pain Management billing team deals with payer delays, coding nuance, and collection leakage. We tighten those weak points before they turn into write-offs.
Pain management procedures face some of the heaviest prior authorization requirements in medicine. Facet injections, epidurals, nerve blocks, and implantable devices all require pre-approval from most payers, with clinical documentation of conservative treatment failure often mandatory.
Facet joint injections (64490-64495) and epidural injections (64483-64484) at multiple spinal levels require correct use of primary and add-on codes, with bilateral modifiers when both sides are treated. Errors in level counting or modifier application are the top cause of pain management denials.
Payers increasingly require documentation of functional improvement from prior injections before authorizing repeat procedures. Demonstrating measurable pain reduction, improved function, and the clinical rationale for continued treatment is essential for authorization approval.
Spinal cord stimulator trials and permanent implants require multi-step authorization including psychological evaluation, conservative treatment documentation, trial period results, and peer-to-peer reviews. The authorization process can take weeks and requires meticulous coordination.
Support spans the full revenue cycle, from front-end verification to denial recovery and reporting.
Facet joint injection coding (64490-64495) with multi-level and bilateral accuracy
Epidural injection billing (64483-64484, 62320-62327) with fluoroscopy documentation
Nerve block coding (64400-64450) with anatomical specificity
Radiofrequency ablation billing (64625-64640) with prior diagnostic block documentation
Spinal cord stimulator trial and implant authorization and billing (63650-63688)
Prior authorization management and peer-to-peer review coordination for all pain procedures
We support independent practices, multisite groups, and growing provider organizations with flexible workflows.
Independent physician groups
Multi-location practices
Private equity backed platforms
Hospital-owned outpatient groups
Pain management billing operates in one of the highest-scrutiny environments in healthcare. Payers apply aggressive prior authorization requirements, medical necessity reviews, and post-payment audits to injection procedures, nerve blocks, and implantable device cases. Injection codes (64490-64495 for facet joint injections, 64483-64484 for transforaminal epidurals) and nerve block codes (64400-64450) require precise anatomical documentation, fluoroscopic guidance confirmation, and clear clinical rationale for each level treated.
Our pain management billing team navigates this challenging landscape by front-loading documentation review, managing prior authorizations proactively, and applying the coding precision that prevents denials before they happen. We handle the full spectrum of pain management procedures, from diagnostic and therapeutic injections to radiofrequency ablation (64625-64640), spinal cord stimulator trials and implants (63650-63688), and intrathecal drug delivery systems. With pain management denial rates industry-wide running 15% to 25%, our proactive approach keeps client denials well below the national average.
Answers to the questions practice owners and managers ask most often before switching billing partners.
Pain management has denial rates of 15% to 25% industry-wide due to aggressive payer scrutiny. Common denial reasons include missing prior authorization, insufficient documentation of conservative treatment failure, incorrect multi-level coding, and failure to demonstrate functional improvement from prior procedures.
The first level uses the primary code (64490 for cervical/thoracic, 64493 for lumbar/sacral). Each additional level at the same spinal region uses the add-on code (64491/64492 or 64494/64495). Bilateral injections require modifier -50 or separate line items with -RT/-LT depending on the payer. We verify level counts against imaging and procedure notes.
Payers want to see documented pain relief percentage from prior injections (typically 50% or greater), functional improvement metrics, duration of relief, and the clinical rationale for continued treatment. We help practices implement standardized outcome tracking that streamlines re-authorization requests.
SCS authorization is a multi-step process: documentation of failed conservative treatment (typically 3-6 months), psychological evaluation clearance, trial stimulator authorization, successful trial results (50%+ pain relief), and permanent implant authorization. We manage each step and coordinate peer-to-peer reviews when needed.
Yes. We code E/M visits for medication management (99213-99215) and ensure documentation supports the selected level, particularly for controlled substance management. We also handle urine drug testing codes (80305-80307, G0480-G0483) with proper medical necessity documentation.
Fluoroscopic guidance (77003) is billed separately from the injection procedure code when it is not bundled. Many injection codes now include imaging guidance in the base code. We verify which procedures allow separate guidance billing and ensure fluoroscopy documentation includes saved images and a formal interpretation.
The difference is operational discipline. We focus on clean submissions, fast follow-up, and transparency.
Get a revenue review and a clear action plan tailored to your practice, payers, and claim mix.